Cargando…
Pre-leukemic clonal hematopoiesis and the risk of therapy-related myeloid neoplasms: a case-control study
BACKGROUND: Therapy-related myeloid neoplasms (t-MNs) are often fatal secondary malignancies. Risk factors for t-MNs are not well understood. Recent studies suggested that individuals with clonal hematopoiesis have higher risk of developing hematological malignancies. We hypothesized that cancer pat...
Autores principales: | Takahashi, Koichi, Wang, Feng, Kantarjian, Hagop, Doss, Denaha, Khanna, Kanhav, Thompson, Erika, Zhao, Li, Patel, Keyur, Neelapu, Sattva, Gumbs, Curtis, Bueso-Ramos, Carlos, DiNardo, Courtney D, Colla, Simona, Ravandi, Farhad, Zhang, Jianhua, Huang, Xuelin, Wu, Xifeng, Samaniego, Felipe, Garcia-Manero, Guillermo, Andrew Futreal, P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5405697/ https://www.ncbi.nlm.nih.gov/pubmed/27923552 http://dx.doi.org/10.1016/S1470-2045(16)30626-X |
Ejemplares similares
-
Clinical implications of TP53 mutations in myelodysplastic syndromes treated with hypomethylating agents
por: Takahashi, Koichi, et al.
Publicado: (2016) -
The history of oral decitabine/cedazuridine and its potential role in acute myeloid leukemia
por: Briski, Robert, et al.
Publicado: (2023) -
IDH1 and IDH2 mutations in myelodysplastic syndromes and role in disease progression
por: DiNardo, Courtney D, et al.
Publicado: (2015) -
Acute myeloid leukemia: current progress and future directions
por: Kantarjian, Hagop, et al.
Publicado: (2021) -
Late relapse in acute myeloid leukemia (AML): clonal evolution or therapy-related leukemia?
por: Yilmaz, Musa, et al.
Publicado: (2019)